Search: onr:"swepub:oai:DiVA.org:uu-131130" >
Further insight int...
Further insight into the roles of the glycans attached to human blood protein C inhibitor
-
- Sun, Wei, 1981- (author)
- Uppsala universitet,Institutionen för medicinsk biokemi och mikrobiologi,Sophia Schedin Weiss' group
-
- Simon, Parry (author)
- Division of Molecular Biosciences, Imperial College London,Anne Dell's group
-
- Ubhayasekera, Wimal (author)
- Lund University,Lunds universitet,MAX IV-laboratoriet,MAX IV Laboratory
-
show more...
-
- Engström, Åke (author)
- Uppsala universitet,Institutionen för medicinsk biokemi och mikrobiologi
-
- Dell, Anne (author)
- Division of Molecular Biosciences, Imperial College London,Anne Dell's group
-
- Schedin-Weiss, Sophia (author)
- Uppsala universitet,Institutionen för medicinsk biokemi och mikrobiologi,Sophia Schedin Weiss' group
-
show less...
-
(creator_code:org_t)
- Elsevier BV, 2010
- 2010
- English.
-
In: Biochemical and Biophysical Research Communications - BBRC. - : Elsevier BV. - 0006-291X .- 1090-2104. ; 403:2, s. 198-202
- Related links:
-
http://dx.doi.org/10...
-
show more...
-
https://urn.kb.se/re...
-
https://doi.org/10.1...
-
https://lup.lub.lu.s...
-
show less...
Abstract
Subject headings
Close
- Protein C inhibitor (PCI) is a 57-kDa glycoprotein that exists in many tissues and secretions in human. As a member of the serpin superfamily of proteins it displays unusually broad protease specificity. PCI is implicated in the regulation of a wide range of processes, including blood coagulation, fertilization, prevention of tumors and pathogen defence. It has been reported that PCI isolated from human blood plasma is highly heterogeneous, and that this heterogeneity is caused by differences in N-glycan structures, N-glycosylation occupancy, and the presence of two forms that differ by the presence or absence of 6 amino acids at the N-terminus. In this study we have verified that such heterogeneity exists in PCI purified from single individuals, and that individuals of two different ethnicities possess a similar PCI pattern, verifying that the microheterogeneity is conserved among humans. Furthermore, we have provided experimental evidence that PCI is O-glycosylated on Thr20 with the O-glycan structure composition NeuAcGalGalNAc. This glycan was conserved in the two individuals and did not contribute to the size heterogeneity. Modeling suggested that the O-glycan attachment site is located in proximity to several ligand-binding sites of the inhibitor.
Subject headings
- MEDICIN OCH HÄLSOVETENSKAP -- Medicinsk bioteknologi -- Medicinsk bioteknologi (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Medical Biotechnology -- Medical Biotechnology (hsv//eng)
- NATURVETENSKAP -- Biologi (hsv//swe)
- NATURAL SCIENCES -- Biological Sciences (hsv//eng)
Keyword
- Microheterogeneity
- Mass spectrometry
- O-glycosylation
- Protein C inhibitor
- Serpin
- Biochemistry
- Biokemi
- Biokemi
- Biochemistry
- Micro-heterogeneity
- Mass spectrometry
- O-glycosylation
- Protein C
- inhibitor
- Serpin
Publication and Content Type
- ref (subject category)
- art (subject category)
Find in a library
To the university's database